Article ; Online: Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma.
The Journal of investigative dermatology
2015 Volume 135, Issue 9, Page(s) 2283–2291
Abstract: Aberrant HGF-MET (hepatocyte growth factor-met proto-oncogene) signaling activation via ... silenced in malignant melanomas. Furthermore, we show that ectopically expressed SPINT2 in melanoma cells ... malignant phenotype potential such as cell motility and invasive growth of melanoma cells. These results ...
Abstract | Aberrant HGF-MET (hepatocyte growth factor-met proto-oncogene) signaling activation via interactions with surrounding stromal cells in tumor microenvironment has significant roles in malignant tumor progression. However, extracellular proteolytic regulation of HGF activation, which is influenced by the tumor microenvironment, and its consequential effects on melanoma malignancy remain uncharacterized. In this study, we identified SPINT2 (serine peptidase inhibitor Kunitz type 2), a proteolytic inhibitor of hepatocyte growth factor activator (HGFA), which has a significant role in the suppression of the HGF-MET pathway and malignant melanoma progression. SPINT2 expression is significantly lower in metastatic melanoma tissues compared with those in early-stage primary melanomas, which also corresponded with DNA methylation levels isolated from tissue samples. Treatment with the DNA-hypomethylating agent decitabine in cultured melanoma cells induced transcriptional reactivation of SPINT2, suggesting that this gene is epigenetically silenced in malignant melanomas. Furthermore, we show that ectopically expressed SPINT2 in melanoma cells inhibits the HGF-induced MET-AKT (v-Akt murine thymoma viral oncogene) signaling pathway and decreases malignant phenotype potential such as cell motility and invasive growth of melanoma cells. These results suggest that SPINT2 is associated with tumor-suppressive functions in melanoma by inhibiting an extracellular signal regulator of HGF, which is typically activated by tumor-stromal interactions. These findings indicate that epigenetic impairment of the tightly regulated cytokine-receptor communications in tumor microenvironment may contribute to malignant tumor progression. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Animals ; Cell Movement/genetics ; Cell Proliferation/genetics ; DNA Methylation ; Epigenesis, Genetic ; Gene Expression Regulation, Neoplastic ; Gene Silencing ; Hepatocyte Growth Factor/genetics ; Hepatocyte Growth Factor/metabolism ; Humans ; Immunoblotting ; Melanoma/genetics ; Melanoma/pathology ; Membrane Glycoproteins/genetics ; Mice ; Mice, Transgenic ; Polymerase Chain Reaction/methods ; Promoter Regions, Genetic ; Serine Endopeptidases ; Signal Transduction/genetics ; Skin Neoplasms/genetics ; Skin Neoplasms/pathology ; Tumor Cells, Cultured | |||||
Chemical Substances | Membrane Glycoproteins ; SPINT2 protein, human ; Hepatocyte Growth Factor (67256-21-7) ; HGF activator (EC 3.4.21.-) ; Serine Endopeptidases (EC 3.4.21.-) | |||||
Language | English | |||||
Publishing date | 2015-09 | |||||
Publishing country | United States | |||||
Document type | Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural | |||||
ZDB-ID | 80136-7 | |||||
ISSN | 1523-1747 ; 0022-202X | |||||
ISSN (online) | 1523-1747 | |||||
ISSN | 0022-202X | |||||
DOI | 10.1038/jid.2015.160 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui VI Zs.124: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.